Herantis Pharma Oyj

HEL:HRTIS.HE

1.69 (EUR) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q2
Operating Activities:
Net Income -2.253-2.6872.075-1.7951.978-11.302-0.005-0.008-2.34-6.812-4.686-3.319-2.415-1.765-0.273-1.891-0.002-0.003-1.23-13.585-4.178-4.178-0.266-0.322-0.197-0.197
Depreciation & Amortization 00000.1600.00200.4640.4640.242-0.2421.202-01.2130.0050.0010.0010.4148.5930.9420.942-0000
Deferred Income Tax 00000000000000000000000000
Stock Based Compensation 00000000000000000000000000
Change In Working Capital -1.257-0.308-0.2480.3570.128-0.1480-00.443-0.7780.495-0.495-0.1310.052-0.1910.5630-0-0.842-0.3441.0391.0390.298-0.142-0.09-0.09
Accounts Receivables -0.2780-0.0160.0080.031-0.13-00-0.0660.111-0.1340.134-0-0.017-0.0710.02700-0.2750.168-0.111-0.1110.043-0.007-0.022-0.022
Change In Inventory 00000000000000000000000000
Change In Accounts Payables 00000.136-0.136000.509-0.5091.124-1.124000000000000-0.068-0.068
Other Working Capital -0.98-0.308-0.2320.349-0.1180.1180-00.255-0.63500-0.0990.038-0.120.5360-0-0.567-0.5121.151.150.255-0.135-0.068-0.068
Other Non Cash Items 0-0.04-3.287-0.279-5.6935.933-0.0020.002-0.4530.4530.7371.309-0.585-0.091-2.3980.3740-0-0.573-00.0160.016-0.0320.0760.020.02
Operating Cash Flow -3.51-3.035-1.46-1.717-3.427-5.517-0.004-0.005-1.887-6.674-3.211-2.747-1.928-1.804-1.649-0.95-0.001-0.002-2.23-5.336-2.18-2.180-0.388-0.267-0.267
Investing Activities:
Investments In Property Plant And Equipment 0000000000000000-0-0-0.0060-0.007-0.0070.421-0-0.887-0.887
Acquisitions Net 0000.607000000.0040000.00700-0000000000
Purchases Of Investments 0-1.5000000000000000000-0.001-0.0010000
Sales Maturities Of Investments -01.026000000000000000000000000
Other Investing Activites 0000-0.21-000-000000-0-0000000-0.422-0.42100
Investing Cash Flow -0-0.47400.607-0.21-000-00.0040000.007-0-0-0-0-0.0060-0.007-0.007-0-0.421-0.887-0.887
Financing Activities:
Debt Repayment 0000-0.150000-0.0060.5750.2560.4730.03500.492000.87100.1570.157000.2160.216
Common Stock Issued 004.5060.001-8.70817.4180086.8894.1635.7820004.68000.32307.7327.73200.880.820.82
Common Stock Repurchased 00000000000000000000000000
Dividends Paid 00000000000000000000000000
Other Financing Activities 2.156-0.005-0.011-0.001-17.41817.4180.004-0-0.0060.0060-0.006-0.2370.2374.907-4.90700-0.5970.334000.171000
Financing Cash Flow 2.156-0.0054.4950.001-8.85917.4180.004-07.9946.8894.7376.0330.2370.2724.9070.265000.5970.3347.8897.8890.1710.881.0361.036
Other Information:
Effect Of Forex Changes On Cash 000000000000000-000-00000000
Net Change In Cash 0-3.51203.926-1.4048.641-0.0070.00706.3271.5264.8120-3.21602.573-0.0040.004-1.0426.6360-0.01800.071-0.237-0.237
Cash At End Of Period 0.6351.9895.5033.9265.0369.48500.00712.33912.3396.0136.998-0.0012.1860.0025.40200.0045.5410.00711.4160-00.0840.0090.009